Mayo Clinic-accelerated AI company completes seed round

AccurKardia, a medical software company using artificial intelligence that the Mayo Clinic selected for its accelerator program, raised $2.7 million in seed funding.

Advertisement

The company was selected to join Rochester, Minn.-based health system’s third cohort of the Platform_Accelerate program. Through the partnership, AccurKardia gained access to Mayo Clinic’s data sets, validation frameworks, clinical workflow planning and mentorship, according to a June 20 AccurKardia news release.

The company focused on delivering the interpretation of electrocardiograms.

“With advances in AI, edge computing capabilities, and ubiquitous connectivity, a perfect storm is brewing to deliver planetary-scale tech-enabled healthcare. Our team is primed to develop groundbreaking, life-changing software to interact with clinical and consumer wearables,” Sadeq Ali, co-founder, chief people officer and chief technology officer of AccurKardia, said in the release.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.